HomeELDN • NASDAQ
add
Eledon Pharmaceuticals Inc
Previous close
$1.58
Day range
$1.58 - $1.65
Year range
$1.35 - $5.08
Market cap
119.30M USD
Avg Volume
3.23M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 19.07M | -7.02% |
Net income | -17.46M | -122.68% |
Net profit margin | — | — |
Earnings per share | -0.21 | 34.38% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 93.40M | 19.45% |
Total assets | 129.86M | 13.34% |
Total liabilities | 38.80M | 0.74% |
Total equity | 91.05M | — |
Shares outstanding | 59.93M | — |
Price to book | 1.04 | — |
Return on assets | -34.70% | — |
Return on capital | -48.01% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -17.46M | -122.68% |
Cash from operations | -14.48M | -23.01% |
Cash from investing | 12.40M | 196.90% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -2.07M | 89.26% |
Free cash flow | -7.99M | -90.42% |
About
Founded
2004
Headquarters
Website
Employees
31
